FOCAL CORTICAL DYSPLASIA TYPE II

Clinical trials for FOCAL CORTICAL DYSPLASIA TYPE II explained in plain language.

Never miss a new study

Get alerted when new FOCAL CORTICAL DYSPLASIA TYPE II trials appear

Sign up with your email to follow new studies for FOCAL CORTICAL DYSPLASIA TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1

New drug radiprodil tested for tough seizures in two brain conditions

Disease control Ongoing

This early-phase trial tests an experimental drug called radiprodil in 30 people with tuberous sclerosis complex or focal cortical dysplasia type II whose seizures have not responded to at least two other medications. The study is open-label, meaning everyone gets the drug, and w…

Matched conditions: FOCAL CORTICAL DYSPLASIA TYPE II

Phase: PHASE1, PHASE2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

FOCAL CORTICAL DYSPLASIA TYPE II

Get alerted when new FOCAL CORTICAL DYSPLASIA TYPE II trials appear

New drug radiprodil tested for tough seizures in two brain conditions